Hospira, Inc.

FDA inspection history in Rocky Mount, North Carolina, 2010 to 2023

8
Form 483s
1
Warning letter

Every document, by year

  • Form 483
  • Warning letter

2010: one Form 483; 2011: two Form 483s; 2013: one Form 483; 2014: one warning letter; 2015: one Form 483; 2018: one Form 483; 2019: one Form 483; 2023: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2010–15Five Form 483s and one warning letter, at Rocky Mount, North Carolina.
  2. 2013The longest 483 on file: 20 observations over 22 pages at Rocky Mount, North Carolina.
  3. 2018–19Two Form 483s, at Rocky Mount, North Carolina.
  4. 2023One Form 483, at Rocky Mount, North Carolina.

Cited most

Across all Hospira observations on file

The complete Hospira file.

All 9 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$757$891

15% off buying them one by one

Sites

Documents

9 on file, newest first
DateDocumentPrice
2023-11-14483 Form 483$99
2019-11-21483 Form 483$99
2018-02-02483 Form 483$99
2015-09-24483 Form 483$99
2014-03-07Warning letter Warning letter$99
2013-03-01483 Form 483$99
2011-08-04483 Form 483$99
2011-06-17483 Form 483$99
2010-01-19483 Form 483$99

FEI number 1021343 · most recent document Nov 14, 2023

About Hospira, Inc.

How many FDA Form 483s has Hospira, Inc. received?

FDA Intel has 8 Form 483s on file for Hospira, Inc.; the most recent is dated Nov 14, 2023.

When was Hospira, Inc. last inspected by FDA?

The most recent FDA inspection document on file for Hospira, Inc. is a Form 483 dated Nov 14, 2023, for the site in Rocky Mount, North Carolina.

What did FDA cite at Hospira, Inc.?

The regulations cited most in the observations on file for Hospira, Inc. are 21 CFR 211.192 (Production record review), 8 times; 21 CFR 211.160 (General requirements), 7 times; 21 CFR 211.42(a) (Design and construction features), 5 times.

Has Hospira, Inc. received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Hospira, Inc.; the most recent is dated Mar 7, 2014.